Diversified Healthcare Trust Common Shares of Beneficial Interest (DHC) is a publicly traded Real Estate sector company. As of July 5, 2026, DHC trades at $9.23 with a market cap of $2.23B and a P/E ratio of -5.96. DHC moved -0.11% today. Year to date, DHC is +95.14%; over the trailing twelve months it is +148.79%. Its 52-week range spans $2.00 to $9.66. Analyst consensus is buy with an average price target of $9.83. Rallies surfaces DHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
DHC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. DHC recently traded at $9.23. Market cap is $2.23B. P/E ratio is -5.96. Revenue is $1.50B.
| Metric | Value |
|---|---|
| Price | $9.23 |
| Market Cap | $2.23B |
| P/E Ratio | -5.96 |
| EPS | $-1.55 |
| Dividend Yield | 0.01% |
| 52-Week High | $9.66 |
| 52-Week Low | $2.00 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.50B |
| Net Income | $-370.25M |
| Gross Margin | 0.00% |
3 analysts cover DHC: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.83.